Randomized Controlled Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms MATEO
- 11 Oct 2016 Trial design presented at the 41st European Society for Medical Oncology Congress.
- 17 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 16 Aug 2014 New source identified and integrated. (European Clinical Trials Database)